NCT04775069View on ClinicalTrials.gov

Antibody Response to COVID-19 Vaccines in Liver Disease Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Chronic Liver Disease
Interventions
BIOLOGICAL

BNT162b2

Intramuscular injection

BIOLOGICAL

CoronaVac

Intramuscular injection

BIOLOGICAL

AZD1222

Intramuscular injection

Trial Locations (1)

Unknown

Humanity & Health Medical Group Limited, Hong Kong

All Listed Sponsors
lead

Humanity & Health Medical Group Limited

OTHER